Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DCTH

Delcath Systems Inc

Nov 18 • 03:17PM ET

8.67

+0.06 0.69 %

Healthcare • Medical Devices • USA • NASD

Peers: MNOV CRMD BLRX PSTV HOOK CYCN AVGR SCPH TTOO

| Held by: VTI IWM VXF IWO SURI VTWO IWC ITOT GSSC VTWG

Scroll to Statements

Index	RUT	P/E	1008.07	EPS (ttm)	0.01	Insider Own	6.73%	Shs Outstand	35.31M	Perf Week	0.57%
Market Cap	306.15M	Forward P/E	24.77	EPS next Y	0.35	Insider Trans	0.49%	Shs Float	32.94M	Perf Month	-24.09%
Enterprise Value	218.20M	PEG	-	EPS next Q	-0.08	Inst Own	50.89%	Short Float	12.88%	Perf Quarter	-16.08%
Income	1.20M	P/S	3.85	EPS this Y	103.07%	Inst Trans	8.32%	Short Ratio	5.16	Perf Half Y	-51.76%
Sales	79.60M	P/B	2.67	EPS next Y	1125.02%	ROA	1.54%	Short Interest	4.24M	Perf YTD	-28.00%
Book/sh	3.25	P/C	3.44	EPS next 5Y	-	ROE	1.94%	52W High	18.23 -52.44%	Perf Year	-6.07%
Cash/sh	2.52	P/FCF	25.43	EPS past 3/5Y	36.35% 69.36%	ROIC	1.04%	52W Low	8.33 4.07%	Perf 3Y	188.98%
Dividend Est.	-	EV/EBITDA	35.25	Sales past 3/5Y	118.74% 88.10%	Gross Margin	86.29%	Volatility	5.19% 6.44%	Perf 5Y	-24.68%
Dividend TTM	-	EV/Sales	2.74	EPS Y/Y TTM	101.70%	Oper. Margin	7.39%	ATR (14)	0.55	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	13.71	Sales Y/Y TTM	251.54%	Profit Margin	1.50%	RSI (14)	35.41	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	15.06	EPS Q/Q	-64.06%	SMA20	-6.39%	Beta	0.44	Target Price	23.14
Payout	-	Debt/Eq	0.01	Sales Q/Q	83.60%	SMA50	-16.49%	Rel Volume	0.62	Prev Close	8.61
Employees	96	LT Debt/Eq	0.01	Earnings	Nov 04 BMO	SMA200	-30.29%	Avg Volume	822.62K	Price	8.67
IPO	Oct 23, 2001	Option/Short	Yes / Yes	EPS/Sales Surpr.	640.54% 0.32%	Trades		Volume	456,447	Change	0.69%

Date	Action	Analyst	Rating Change	Price Target Change
Jun-28-24	Initiated	Craig Hallum	Buy	$18
May-14-24	Initiated	Stephens	Overweight	$25
Jul-26-22	Resumed	Canaccord Genuity	Buy	$17
Dec-10-21	Initiated	H.C. Wainwright	Buy	$25
Mar-09-21	Initiated	Canaccord Genuity	Buy	$24
Jan-05-21	Initiated	BTIG Research	Buy	$23
Jun-01-20	Initiated	Laidlaw	Buy	$19

Today 08:00AM	Delcath Systems Announces Publication of Expert Narrative Review on Percutaneous Hepatic Perfusion for Liver Metastases from Uveal Melanoma (Business Wire)
05:07AM	H.C. Wainwright Reiterates a Buy on Delcath Systems (DCTH), Lowers the PT (Insider Monkey)
Nov-14-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-13-25 08:30AM	Delcath Systems Announces Publication of Real-World Evidence Supporting Early Use of Liver-Directed Therapy with PHP in Achieving Long-Term Survival for Metastatic Uveal Melanoma Patients (Business Wire)
Nov-06-25 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
04:06PM	Loading…
Nov-04-25 04:06PM	Delcath Systems Inc (DCTH) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
09:15AM	Delcath Systems, Inc. (DCTH) Q3 Earnings Match Estimates (Zacks)
08:00AM	Delcath Systems Reports Third Quarter 2025 Results and Business Highlights (Business Wire)
Oct-27-25 04:43PM	Short Sellers Are Targeting Small-Caps. Megacaps Are Getting a Pass. (Barrons.com)
Oct-21-25 08:30AM	Delcath Systems to Host Third Quarter 2025 Earnings Call (Business Wire)
Oct-18-25 04:15PM	Delcath Systems Announces Preliminary Third Quarter 2025 Financial Results (Business Wire)
04:13PM	Delcath Systems Announces Investigator-Initiated CHOPIN Clinical Trial Meets Primary Endpoint (Business Wire)
Sep-22-25 04:01PM	Delcath Systems Announces Investigator-Initiated CHOPIN Phase 2 Trial Presentation at ESMO 2025 Congress (Business Wire)
Sep-05-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-04-25 02:52PM	Invesco Backs Delcath Systems (DCTH) on Expansion Potential (Insider Monkey)
08:30AM	Loading…
Aug-21-25 08:30AM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Aug-19-25 08:30AM	Delcath Systems Announces First Patient Dosed in Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer (Business Wire)
Aug-13-25 12:08PM	H.C. Wainwright Remains Bullish on Delcath Systems (DCTH) (Insider Monkey)
Aug-06-25 09:15AM	Delcath Systems, Inc. (DCTH) Surpasses Q2 Earnings and Revenue Estimates (Zacks)
08:00AM	Delcath Systems Reports Second Quarter 2025 Results and Business Highlights (Business Wire)
Jul-29-25 04:01PM	Delcath Systems to Participate at the Canaccord Genuity 45th Annual Growth Conference (Business Wire)
Jul-28-25 05:15PM	Ekso Bionics (EKSO) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
Jul-25-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-23-25 04:01PM	Delcath Systems to Host Second Quarter 2025 Earnings Call (Business Wire)
Jul-17-25 08:32AM	Is the Options Market Predicting a Spike in Delcath Systems Stock? (Zacks)
Jun-04-25 12:00PM	Delcath Systems, Inc. (DCTH) Is Up 0.62% in One Week: What You Should Know (Zacks)
09:40AM	Is Benitec Biopharma (BNTC) Outperforming Other Medical Stocks This Year? (Zacks)
May-28-25 09:55AM	Wall Street Analysts Predict a 48.69% Upside in Delcath Systems (DCTH): Here's What You Should Know (Zacks)
08:50AM	Here's Why Momentum in Delcath Systems (DCTH) Should Keep going (Zacks)
May-22-25 07:00AM	Delcath Systems Issues Full Year 2025 Guidance (Business Wire) -6.32%
04:30PM	Loading…
May-15-25 04:30PM	Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference (Business Wire) +6.54%
May-09-25 05:30PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
03:15AM	Delcath Systems Inc (DCTH) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
May-08-25 08:45AM	Delcath Systems, Inc. (DCTH) Misses Q1 Earnings Estimates (Zacks) +23.64%
07:30AM	Delcath Systems Reports First Quarter 2025 Results and Business Highlights (Business Wire)
May-07-25 06:00PM	Here are the major earnings before the open tomorrow (Seeking Alpha)
02:21PM	Delcath Systems Q1 2025 Earnings Preview (Seeking Alpha)
May-06-25 07:10AM	Waters (WAT) Q1 Earnings and Revenues Beat Estimates (Zacks)
Apr-28-25 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Breast Cancer (Business Wire)
Apr-27-25 09:22AM	Immunocore Holdings: A Name On My Watch List (Seeking Alpha)
Apr-24-25 04:01PM	Delcath Systems to Host First Quarter 2025 Earnings Call (Business Wire)
Apr-10-25 09:03AM	Delcath Systems (DCTH) Soars 9.8%: Is Further Upside Left in the Stock? (Zacks) -7.71%
Apr-09-25 05:00PM	Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma (Business Wire) +9.82%
Apr-02-25 11:49AM	Hospitals Experience FOMO In Adopting Delcath's PHP Treatment (Seeking Alpha)
Mar-27-25 04:45PM	Beta Bionics Announces Board Appointment of Gerard Michel (GlobeNewswire)
10:46AM	Jim Cramer Blesses Delcath Systems (DCTH): 'You're Not Early, But It's a Win' (InsiderMonkey)
Mar-26-25 09:55AM	Wall Street Analysts See a 58.49% Upside in Delcath Systems (DCTH): Can the Stock Really Move This High? (Zacks) -6.52%
Mar-24-25 04:01PM	Delcath Systems to Participate at the Canaccord Genuity Horizons in Oncology Virtual Conference (Business Wire)
Mar-19-25 09:40AM	Is aTyr Pharma (ATYR) Stock Outpacing Its Medical Peers This Year? (Zacks)
Mar-14-25 04:01PM	Delcath Systems, Inc. Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-06-25 08:00AM	Delcath Systems Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
Feb-20-25 08:30AM	Delcath Systems to Host Fourth Quarter and Full Year 2024 Earnings Call (Business Wire)
Feb-14-25 08:30AM	Delcath Systems Announces Update to National Comprehensive Cancer Network Clinical Practice Guidelines for the Treatment of Metastatic Uveal Melanoma (Business Wire)
Jan-31-25 07:00AM	Biotech walks a 'tightrope' amid unclear funding, regulations (Yahoo Finance Video)
Jan-28-25 04:01PM	Delcath Systems to Participate at the BTIG Annual MedTech, Digital Health, Life Science & Diagnostic Tools Conference (Business Wire)
Jan-15-25 02:31PM	Delcath Systems, Inc. (DCTH): Analysts Recommend This 52-Week High Stocks Now (Insider Monkey)
Jan-13-25 08:00AM	Delcath Systems Announces Preliminary Fourth Quarter and Full Year 2024 Financial Results (Business Wire) +11.41%
Jan-03-25 04:01PM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Dec-30-24 08:00AM	Delcath Systems Announces Additional $16.3 Million in Funding From Series E and E1 Warrant Exercises (Business Wire)
Dec-02-24 08:30AM	Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO in Liver-Dominant Metastatic Colorectal Cancer (Business Wire) +6.40%
Nov-09-24 04:00PM	Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-08-24 08:00AM	Delcath Systems Reports Third Quarter 2024 Results and Business Highlights (Business Wire)
Nov-01-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-24 08:30AM	Delcath Systems to Host Third Quarter 2024 Earnings Call (Business Wire)
Oct-17-24 08:30AM	Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results (Business Wire) +7.57%
Sep-20-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Sep-16-24 08:30AM	Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT in Metastatic Uveal Melanoma Subgroups (Business Wire)
Aug-28-24 04:01PM	Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients (Business Wire)
04:01PM	Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference (Business Wire)
Aug-27-24 08:30AM	Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients (Business Wire) +15.57%
Aug-26-24 04:01PM	Delcath Systems, Inc. Announces Promising Results from Independent Study on Repeated Hepatic Chemosaturation for Liver Tumors (Business Wire) +13.86%
Aug-20-24 08:30AM	Delcath Systems Announces Poster Presentation at the 2024 ESMO Congress (Business Wire)
Aug-12-24 04:01PM	Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-05-24 08:59PM	DCTH Stock Earnings: Delcath Systems Misses EPS, Beats Revenue for Q2 2024 (InvestorPlace)
04:01PM	Delcath Systems Reports Second Quarter 2024 Results and Business Highlights (Business Wire)
08:30AM	Delcath Systems Announces CMS Approval for NTAP for HEPZATO KIT (Business Wire)
Jul-30-24 04:01PM	Delcath Systems to Participate in Upcoming Investor Conferences (Business Wire)
Jul-22-24 04:01PM	Delcath Systems to Host Second Quarter 2024 Earnings Call (Business Wire)
Jul-15-24 12:00PM	Delcath Systems, Inc. (DCTH) is a Great Momentum Stock: Should You Buy? (Zacks)
Jun-14-24 08:50AM	Here's What Could Help Delcath Systems (DCTH) Maintain Its Recent Price Strength (Zacks)
Jun-03-24 09:55AM	Does Delcath Systems (DCTH) Have the Potential to Rally 197.87% as Wall Street Analysts Expect? (Zacks)
May-28-24 09:30AM	Delcath Systems Announces Appointment of Bridget Martell, MA, MD to Delcath's Board of Directors (Business Wire) -5.53%
May-17-24 09:55AM	Wall Street Analysts Predict a 201.72% Upside in Delcath Systems (DCTH): Here's What You Should Know (Zacks) +8.76%
May-15-24 08:50AM	What Makes Delcath Systems (DCTH) a Good Fit for 'Trend Investing' (Zacks)
03:02AM	Delcath Systems Inc (DCTH) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ... (GuruFocus.com)
May-14-24 11:52AM	DCTH Stock Earnings: Delcath Systems Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace) +30.93%
07:30AM	Delcath Systems Reports First Quarter 2024 Results and Business Highlights (PR Newswire)
May-07-24 08:30AM	Delcath Systems to Host First Quarter 2024 Earnings Call (PR Newswire)
May-06-24 09:00AM	Publication of Results from Pivotal FOCUS Study in Metastatic Uveal Melanoma Patients treated with HEPZATO KIT (PR Newswire)
May-03-24 05:15PM	Delcath Systems Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-23-24 09:55AM	How Much Upside is Left in Delcath Systems (DCTH)? Wall Street Analysts Think 244.83% (Zacks)
Apr-05-24 09:55AM	Can Delcath Systems (DCTH) Climb 277.73% to Reach the Level Wall Street Analysts Expect? (Zacks)
Apr-04-24 08:35AM	Delcath Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) (PR Newswire)
Apr-02-24 12:00PM	Delcath Systems (DCTH) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Mar-27-24 11:50AM	Delcath Systems, Inc. (NASDAQ:DCTH) Q4 2023 Earnings Call Transcript (Insider Monkey) +10.41%
Mar-26-24 11:52AM	DCTH Stock Earnings: Delcath Systems Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
09:12AM	Delcath Systems Inc (DCTH) Reports Mixed Year-End Financials Amidst Strategic Advancements (GuruFocus.com)
08:40AM	Delcath Systems, Inc. (DCTH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
07:30AM	Delcath Systems Reports Fourth Quarter and Full Year 2023 Results and Provides Business Update (PR Newswire)
Mar-22-24 02:43PM	Hedge Fund and Insider Trading News: David Tepper, Ken Griffin, Starboard Value, ExodusPoint Capital, Elliott Management, Three Arrows Capital, Delcath Systems Inc (DCTH), Dell Technologies Inc (DELL), and More (Insider Monkey)

Delcath Systems, Inc. is an oncology company, which engages in the treatment of primary and metastatic liver cancers. Its products include CHEMOSAT and HEPZATO. The company was founded on August 5, 1988 and is headquartered in Queensbury, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
MICHEL GERARD J	CHIEF EXECUTIVE OFFICER	Nov 11 '25	Buy	8.53	11,500	98,049	330,834	Nov 13 11:53 AM
Vukovic Vojo	CHIEF MEDICAL OFFICER	Jun 12 '25	Option Exercise	4.78	42,000	200,760	168,882	Jun 13 05:22 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DCTH

Delcath Systems Inc

Upgrade your FINVIZ experience